5 Einträge gefunden

1. High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

   1. Heumann, Asmus
   2. Heinemann, Nina
   3. Hube-Magg, Claudia
   4. Lang, Dagmar S
   5. Grupp, Katharina
   6. Kluth, Martina
   7. Minner, Sarah

   2018 - Forschungsinformationssystem des UKE - frei zugänglich
2. Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability, and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer

   1. Wilczak, Waldemar
   2. Rashed, Semin
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Simon, Ronald
   6. Büscheck, Franziska
   7. Clauditz, Till Sebastian

   2017 - Forschungsinformationssystem des UKE
3. Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion

   1. Grupp, Katharina
   2. Roettger, Laura
   3. Kluth, Martina
   4. Hube-Magg, Claudia
   5. Simon, Ronald
   6. Lebok, Patrick
   7. Minner, Sarah

   2015 - Forschungsinformationssystem des UKE
4. High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers

   1. Grupp, Katharina
   2. Sanader, Stella
   3. Sirma, Hüseyin
   4. Simon, Ronald
   5. Koop, Christina
   6. Prien, Kristina
   7. Hube-Magg, Claudia

   2013 - Forschungsinformationssystem des UKE - frei zugänglich
5. Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence.

   1. Grupp, Katharina
   2. Kohl, Sebastian
   3. Sirma, Hüseyin
   4. Simon, Ronald
   5. Steurer, Stefan
   6. Becker, Andreas
   7. Adam, Meike

   2013 - Forschungsinformationssystem des UKE